Authors:
WALLACE EM
CROSSLEY JA
RILEY SC
BALFOUR C
GROOME NP
AITKEN DA
Citation: Em. Wallace et al., INHIBIN-B AND PRO-ALPHA-C-CONTAINING INHIBINS IN AMNIOTIC-FLUID FROM CHROMOSOMALLY NORMAL AND DOWN-SYNDROME PREGNANCIES, Prenatal diagnosis, 18(3), 1998, pp. 213-217
Authors:
WALLACE EM
CROSSLEY JA
RITOE SC
AITKEN DA
SPENCER K
GROOME NP
Citation: Em. Wallace et al., EVOLUTION OF AN INHIBIN-A ELISA METHOD - IMPLICATIONS FOR DOWNS-SYNDROME SCREENING, Annals of clinical biochemistry, 35, 1998, pp. 656-664
Citation: Da. Aitken et Ja. Crossley, NEURAL-TUBE DEFECTS ALPHA-FETOPROTEIN/DOWNS-SYNDROME SCREENING/, Current opinion in obstetrics & gynecology, 9(2), 1997, pp. 113-120
Authors:
WALLACE EM
CROSSLEY JA
RITOE SC
GROOME NP
AITKEN DA
Citation: Em. Wallace et al., MATERNAL SERUM INHIBIN-A IN PREGNANCIES COMPLICATED BY INSULIN-DEPENDENT DIABETES-MELLITUS, British journal of obstetrics and gynaecology, 104(8), 1997, pp. 946-948
Authors:
BERRY E
AITKEN DA
CROSSLEY JA
MACRI JN
CONNOR JM
Citation: E. Berry et al., SCREENING FOR DOWNS-SYNDROME - CHANGES IN MARKER LEVELS AND DETECTIONRATES BETWEEN FIRST AND 2ND TRIMESTERS, British journal of obstetrics and gynaecology, 104(7), 1997, pp. 811-817
Authors:
NEWBY D
AITKEN DA
CROSSLEY JA
HOWATSON AG
MACRI JN
CONNOR JM
Citation: D. Newby et al., BIOCHEMICAL MARKERS OF TRISOMY-21 AND THE PATHOPHYSIOLOGY OF DOWNS-SYNDROME PREGNANCIES, Prenatal diagnosis, 17(10), 1997, pp. 941-951
Authors:
WALLACE EM
CROSSLEY JA
GROOME NP
AITKEN DA
Citation: Em. Wallace et al., AMNIOTIC-FLUID INHIBIN-A IN CHROMOSOMALLY NORMAL AND DOWNS-SYNDROME PREGNANCIES, Journal of Endocrinology, 152(1), 1997, pp. 109-112
Authors:
WALLACE EM
RILEY SC
CROSSLEY JA
RITOE SC
HORNE A
SHADE M
ELLIS PM
AITKEN DA
GROOME NP
Citation: Em. Wallace et al., DIMERIC INHIBINS IN AMNIOTIC-FLUID, MATERNAL SERUM, AND FETAL SERUM, AND FETAL SERUM HUMAN-PREGNANCY, The Journal of clinical endocrinology and metabolism, 82(1), 1997, pp. 218-222
Authors:
AITKEN DA
CROSSLEY JA
GRAHAM ES
MCCORMICK C
BERRY E
CONNOR JM
Citation: Da. Aitken et al., RATES OF CHANGE IN MATERNAL SERUM SP1 LEVELS IN DOWNS-SYNDROME PREGNANCIES BETWEEN THE FIRST AND 2ND TRIMESTERS, American journal of human genetics, 61(4), 1997, pp. 828-828
Citation: Ja. Crossley et al., BIOCHEMICAL SCREENING FOR DOWNS-SYNDROME - EXPERIENCE AND IMPACT OF 4YEARS SCREENING IN THE WEST OF SCOTLAND, American journal of human genetics, 61(4), 1997, pp. 2208-2208
Citation: Ja. Crossley et al., INSULIN-DEPENDENT DIABETES-MELLITUS AND PRENATAL SCREENING RESULTS - CURRENT EXPERIENCE FROM A REGIONAL SCREENING-PROGRAM, Prenatal diagnosis, 16(11), 1996, pp. 1039-1042
Authors:
AITKEN DA
SYVERTSEN BS
CROSSLEY JA
BERRY E
CONNOR JM
Citation: Da. Aitken et al., HEAT-STABLE AND IMMUNOREACTIVE PLACENTAL ALKALINE-PHOSPHATASE IN MATERNAL SERUM FROM DOWNS-SYNDROME AND TRISOMY-18 PREGNANCIES, Prenatal diagnosis, 16(11), 1996, pp. 1051-1054
Authors:
AITKEN DA
WALLACE EM
CROSSLEY JA
SWANSTON IA
VANPAREREN Y
VANMAARLE M
GROOME NP
MACRI JN
CONNOR JM
Citation: Da. Aitken et al., DIMERIC INHIBIN A AS A MARKER FOR DOWNS-SYNDROME IN EARLY-PREGNANCY, The New England journal of medicine, 334(19), 1996, pp. 1231-1236
Authors:
BERRY E
AITKEN DA
CROSSLEY JA
MACRI JN
CONNOR JM
Citation: E. Berry et al., ANALYSIS OF MATERNAL SERUM ALPHA-FETOPROTEIN AND FREE BETA-HUMAN CHORIONIC-GONADOTROPIN IN THE FIRST TRIMESTER - IMPLICATIONS FOR DOWNS-SYNDROME SCREENING, Prenatal diagnosis, 15(6), 1995, pp. 555-565
Citation: Ja. Crossley et al., IMPACT OF SCREENING USING MATERNAL SERUM AFP AND HCG ON THE BIRTH INCIDENCE OF DOWNS-SYNDROME IN THE WEST OF SCOTLAND, Journal of Medical Genetics, 31(2), 1994, pp. 166-166
Authors:
AITKEN DA
MCKINNON D
CROSSLEY JA
GRAHAM GW
BERRY E
SPENCER K
MACRI JN
CONNOR JM
Citation: Da. Aitken et al., CHANGES IN THE MATERNAL SERUM CONCENTRATIONS OF PAPP-A AND SP-1 IN DOWNS-SYNDROME PREGNANCIES BETWEEN THE FIRST AND 2ND TRIMESTERS, Journal of Medical Genetics, 31(2), 1994, pp. 170-170
Authors:
SPENCER K
AITKEN DA
CROSSLEY JA
MCCAW G
BERRY E
ANDERSON R
CONNER JM
MACRI JN
Citation: K. Spencer et al., FIRST TRIMESTER BIOCHEMICAL SCREENING FOR TRISOMY-21 - THE ROLE OF FREE BETA-HCG, ALPHA-FETOPROTEIN AND PREGNANCY-ASSOCIATED PLASMA-PROTEINA, Annals of clinical biochemistry, 31, 1994, pp. 447-454
Authors:
AITKEN DA
MCCAW G
CROSSLEY JA
BERRY E
CONNOR JM
SPENCER K
MACRI JN
Citation: Da. Aitken et al., 1ST-TRIMESTER BIOCHEMICAL SCREENING FOR FETAL CHROMOSOME-ABNORMALITIES AND NEURAL-TUBE DEFECTS, Prenatal diagnosis, 13(8), 1993, pp. 681-689
Citation: Ja. Crossley et al., 2ND-TRIMESTER UNCONJUGATED ESTRIOL LEVELS IN MATERNAL SERUM FROM CHROMOSOMALLY ABNORMAL PREGNANCIES USING AN OPTIMIZED ASSAY, Prenatal diagnosis, 13(4), 1993, pp. 271-280
Authors:
SPENCER K
MACRI JN
ANDERSON RW
AITKEN DA
BERRY E
CROSSLEY JA
WOOD PJ
COOMBES EJ
STROUD M
WORTHINGTON DJ
DORAN J
BARBOUR H
WILMOT R
Citation: K. Spencer et al., DUAL ANALYTE IMMUNOASSAY IN NEURAL-TUBE DEFECT AND DOWNS-SYNDROME SCREENING - RESULTS OF A MULTICENTER CLINICAL-TRIAL, Annals of clinical biochemistry, 30, 1993, pp. 394-401